Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2017

01-08-2017 | UNM Clinical Case Conferences

Jaundice: A Thyroid Problem?

Authors: Chinemerem J. Okwara, Amirkaveh Mojtahed, Michael Gavin, Joshua Hanson, Denis McCarthy

Published in: Digestive Diseases and Sciences | Issue 8/2017

Login to get access

Excerpt

A 19-year-old Native American male with a history of vitiligo and appendectomy was evaluated by his primary care physician (PCP) with complaints of worsening tachycardia, tremulousness, and a 45-pound unintentional weight loss all occurring over 6 weeks. Since these developments had been noticed by his mother and sister, both of whom had suffered from hyperthyroidism, they urged him to discuss them with his primary care physician. Laboratory tests of thyroid function revealed serum concentrations of thyroid stimulating hormone (TSH) of 0.1 µIU/mL (0.358–3.740) and free thyroxine (fT4) 6.9 ng/dL (0.7–1.6). Treatment was begun with propranolol 20 mg, p.o., t.i.d. for symptomatic hyperthyroidism, pending an urgent consultation with the endocrinology service. Several days after his first meeting with his PCP, he reported the passage of dark urine for 4 days, yellowish discoloration of his skin and eyes for 3 days, and, on reflection, reported itching of his skin, present for 3 weeks. Additional laboratory test results now revealed serum concentrations of total bilirubin 5.5 mg/dL (0.3–1.2), aspartate aminotransferase (AST) 223 U/L (6–38), and alanine aminotransferase (ALT) 258 U/L (13–63); alkaline phosphatase and γ-glutamyl transpeptidase were not measured or recorded. Although on questioning he complained of intolerance to heat, but no dyspnea, chest or neck discomfort or hyperactivity, he reported that 2 weeks previously he had experienced several days of watery diarrhea that had now resolved. His medication history included a single intramuscular injection of 1.2 million units of penicillin G given one week previously for a sore throat due to a presumed streptococcal throat infection. Onset of the jaundice occurred 3 days later. Apart from the propranolol and penicillin, he had taken no other medications, supplements, herbal products, or any drugs of abuse. Given recently diagnosed hyperthyroidism, elevated liver enzyme concentrations in serum, and pruritus with painless jaundice, he was hospitalized for further evaluation. …
Literature
1.
go back to reference Soylu A, Taskale MG, Ciltas A, Kalayci M, et al. Intrahepatic cholestasis in subclinical and overt hyperthyroidism: two case reports. J Med Case Rep. 2008. doi:10.1186/1752-1947-2-116. Soylu A, Taskale MG, Ciltas A, Kalayci M, et al. Intrahepatic cholestasis in subclinical and overt hyperthyroidism: two case reports. J Med Case Rep. 2008. doi:10.​1186/​1752-1947-2-116.
2.
go back to reference Soysal D, Tatar E, Solmaz Ş, Kabayegit O, et al. A case of severe cholestatic jaundice associated with Graves’ disease. Turkish J Gastroenterol. 2008;19:77–79. Soysal D, Tatar E, Solmaz Ş, Kabayegit O, et al. A case of severe cholestatic jaundice associated with Graves’ disease. Turkish J Gastroenterol. 2008;19:77–79.
3.
go back to reference Regelmann MO, Miloh T, Arnon R, Morotti R, et al. Graves’ Disease Presenting with Severe Cholestasis. Thyroid. 2012;22:437–439.CrossRefPubMed Regelmann MO, Miloh T, Arnon R, Morotti R, et al. Graves’ Disease Presenting with Severe Cholestasis. Thyroid. 2012;22:437–439.CrossRefPubMed
4.
go back to reference Sjoberg G, Katzman P, Hallengren B. Liver Cholestasis in Thyrotoxicosis: a Case Report. Int J Endo Metab. 2007;1:44–48. Sjoberg G, Katzman P, Hallengren B. Liver Cholestasis in Thyrotoxicosis: a Case Report. Int J Endo Metab. 2007;1:44–48.
5.
go back to reference Kibirige D, Kiggundu D, Sanya R, Mutebi E. Cholestatic hepatic injury due to a thyroid storm: a case report from a resource limited setting. Thyroid Res. 2012. doi:10.1186/1756-6614-5-6. Kibirige D, Kiggundu D, Sanya R, Mutebi E. Cholestatic hepatic injury due to a thyroid storm: a case report from a resource limited setting. Thyroid Res. 2012. doi:10.​1186/​1756-6614-5-6.
6.
go back to reference Usta Y, Massaad J, Parekh S, Knecht L. Severe cholestatic jaundice secondary to hyperthyroidism. IJCRI. 2013;4:212–215.CrossRef Usta Y, Massaad J, Parekh S, Knecht L. Severe cholestatic jaundice secondary to hyperthyroidism. IJCRI. 2013;4:212–215.CrossRef
7.
go back to reference Myers RP, Cerini R, Sayegh R, Moreau R, et al. Cardiac hepatopathy: clinical, hemodynamic and histologic characteristics and correlations. Hepatology. 2003;37:393–400.CrossRefPubMed Myers RP, Cerini R, Sayegh R, Moreau R, et al. Cardiac hepatopathy: clinical, hemodynamic and histologic characteristics and correlations. Hepatology. 2003;37:393–400.CrossRefPubMed
8.
go back to reference Fernández V, Castillo I, Tapia G, Romanque P, et al. Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat. Hepatology. 2007;45:170–177.CrossRefPubMed Fernández V, Castillo I, Tapia G, Romanque P, et al. Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat. Hepatology. 2007;45:170–177.CrossRefPubMed
9.
go back to reference Girard JP, Haenni B, Bergoz R, Kapanci Y, Cruchaud A. Lupoid hepatitis following administration of penicillin. Case report and immunological studies. Helv Med Acta. 1967;34:23–35.PubMed Girard JP, Haenni B, Bergoz R, Kapanci Y, Cruchaud A. Lupoid hepatitis following administration of penicillin. Case report and immunological studies. Helv Med Acta. 1967;34:23–35.PubMed
Metadata
Title
Jaundice: A Thyroid Problem?
Authors
Chinemerem J. Okwara
Amirkaveh Mojtahed
Michael Gavin
Joshua Hanson
Denis McCarthy
Publication date
01-08-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4668-x

Other articles of this Issue 8/2017

Digestive Diseases and Sciences 8/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.